Join
Live feed
·
INSIDERFilingvia Quantisnow
Stoke Therapeutics Inc. logo

GENERAL COUNSEL & CORP SEC Allan Jonathan sold $16,509 worth of shares (627 units at $26.33) as part of a pre-agreed trading plan, decreasing direct ownership by 3% to 20,598 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
STOK· Stoke Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track STOK (Stoke Therapeutics Inc.) and more on Quantisnow.